Inactive
Notice ID:W81XWH22R0106
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with the...
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with the policies and procedures for solicitation, evaluation and award prescribed in FAR Part 13-Simplified Acquisition Procedures, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and no other solicitation will be issued. The US Army Medical Research Acquisition Activity (USAMRAA) requests responses from qualified sources capable of determining the concentration of per- and polyfluoroalkyl substances (PFAS) analytes in various matrices via Environmental Protections Agency (EPA) Draft Method 1633. The NAICS code is 541380, Testing Laboratories, with a size standard of $16.5M. This is a requirement issued under full and open competition. All capable vendors are encouraged to submit a proposal. Please see the attached document for details on this requirement, how proposals shall be submitted, and how evaluations will take place. Questions pertaining to the solicitation requirements shall be submitted no later than 5:00 PM Eastern Time, 31 August 2022 to the Contract Specialist at jesse.d.nisley.civ@health.mil. The Offeror shall submit one set of questions only; multiple e-mails will not be accepted. Questions not submitted electronically will not be answered; telephone inquiries will not be accepted or acknowledged. Follow up/additional questions will not be accepted after this date. Answers to all relevant and appropriate questions will be issued via amendment to the solicitation. *Amendment 0001 to the combined synopsis/solicitation has been issued to address all questions received from potential offerors. Please see attachment for details.*
